id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-N-0493-0013,FDA,FDA-2010-N-0493,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2020-12-29T05:00:00Z,2020,12,2020-12-29T05:00:00Z,,2020-12-29T17:10:19Z,2020-28608,0,0,09000064849cfdc6
FDA-2010-N-0493-0012,FDA,FDA-2010-N-0493,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Additional Criteria and Procedures for Classifying Overthe-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded—Time and Extent Applications for Nonprescription Drug Products,Notice,30 Day Proposed Information Collection,2020-10-22T04:00:00Z,2020,10,2020-10-22T04:00:00Z,2020-11-24T04:59:59Z,2020-10-22T12:58:43Z,2020-23357,0,0,0900006484923cea
FDA-2010-N-0493-0011,FDA,FDA-2010-N-0493,Agency Information Collection Activities; Proposed Collection; Comment Request; Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded—Time and Extent Applications for Nonprescription Drug Products,Notice,60 Day Proposed Information Collection,2020-07-30T04:00:00Z,2020,7,2020-07-30T04:00:00Z,2020-09-29T03:59:59Z,2020-07-30T13:30:08Z,2020-16528,0,0,09000064847bd2f1
FDA-2010-N-0493-0010,FDA,FDA-2010-N-0493,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2018-02-15T05:00:00Z,2018,2,2018-02-15T05:00:00Z,,2018-02-15T17:59:58Z,2018-03128,0,0,0900006482f35a7c
FDA-2010-N-0493-0009,FDA,FDA-2010-N-0493,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Additional Criteria
and Procedures for Classifying Over-the-Counter Drugs as Generally
Recognized as Safe and Effective and Not Misbranded",Notice,30 Day Proposed Information Collection,2017-08-23T04:00:00Z,2017,8,2017-08-23T04:00:00Z,2017-09-23T03:59:59Z,2017-08-23T13:56:50Z,2017-17842,0,0,0900006482a9e2eb
FDA-2010-N-0493-0008,FDA,FDA-2010-N-0493,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Additional Criteria and Procedures for Classifying Overthe-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded",Notice,60 Day Proposed Information Collection,2017-05-30T04:00:00Z,2017,5,2017-05-30T04:00:00Z,2017-08-01T03:59:59Z,2017-05-30T15:32:04Z,2017-11008,0,0,0900006482665ebf
FDA-2010-N-0493-0007,FDA,FDA-2010-N-0493,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approval; Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded",Notice,Notice of Approval,2014-10-08T04:00:00Z,2014,10,2014-10-08T04:00:00Z,,2017-01-26T17:37:58Z,2014-23956,0,0,09000064818b1c32
FDA-2010-N-0493-0006,FDA,FDA-2010-N-0493,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Additional Criteria
and Procedures for Classifying Overthe- Counter Drugs as Generally
Recognized as Safe and Effective and Not Misbranded",Notice,30 Day Proposed Information Collection,2014-06-25T04:00:00Z,2014,6,2014-06-25T04:00:00Z,2014-07-26T03:59:59Z,2017-01-26T17:37:08Z,2014-14767,0,0,090000648176560d
FDA-2010-N-0493-0005,FDA,FDA-2010-N-0493,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Additional Criteria and Procedures for Classifying Overthe-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded",Notice,60 Day Proposed Information Collection,2014-03-24T04:00:00Z,2014,3,2014-03-24T04:00:00Z,2014-05-24T03:59:59Z,2017-01-26T17:35:20Z,2014-06365,0,0,090000648167969c
FDA-2010-N-0493-0004,FDA,FDA-2010-N-0493,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Safe, etc.",Notice,Notice of Approval,2011-07-11T04:00:00Z,2011,7,2011-07-11T04:00:00Z,,2017-01-26T17:32:22Z,2011-17280,0,0,0900006480ebef87
FDA-2010-N-0493-0003,FDA,FDA-2010-N-0493,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Additional Criteria and Procedures for Classifying Over-the-Counter Drugs, etc.",Notice,30 Day Proposed Information Collection,2011-02-08T05:00:00Z,2011,2,2011-02-08T05:00:00Z,2011-03-11T04:59:59Z,2017-01-26T17:31:29Z,2011-2692,0,0,0900006480be0ee6
FDA-2010-N-0493-0001,FDA,FDA-2010-N-0493,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded",Notice,60 Day Proposed Information Collection,2010-10-08T04:00:00Z,2010,10,2010-10-08T04:00:00Z,2010-12-08T04:59:59Z,2017-01-26T17:30:50Z,2010-25375,0,0,0900006480b6a0cf